相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan
Robyn J. Barst et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
Anna Fijalkowska et al.
CHEST (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Ambrisentan therapy for pulmonary arterial hypertension
N Galié et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Clinical significance of brain natriuretic peptide in primary pulmonary hypertension
HH Leuchte et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
The endothelin system in pulmonary arterial hypertension
N Galié et al.
CARDIOVASCULAR RESEARCH (2004)
US healthcare: The intertwined caduceus of physicians, coverage, quality, and cost
A Garson
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Combination of bosentan with epoprostenol in pulmonary arterial hypertension:: BREATHE-2
M Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Medical therapy for pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
DB Badesch et al.
CHEST (2004)
Guidelines on diagnosis and treatment of pulmonary arterial hypertension -: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
N Galiè et al.
EUROPEAN HEART JOURNAL (2004)
Diagnosis and differential assessment of pulmonary arterial hypertension
RJ Barst et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension
N Galiè et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Mechanisms of disease: Pulmonary arterial hypertension
HW Farber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Beraprost therapy for pulmonary arterial hypertension
RJ Barst et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Inhaled iloprost for severe pulmonary hypertension
H Olschewski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension:: With pulmonary arterial hypertension:: A randomized, double-blind, placebo-controlled trial
N Galiè et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
G Simonneau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
ETA and ETB receptors modulate the proliferation of human pulmonary artery smooth muscle cells
N Davie et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
RN Channick et al.
LANCET (2001)
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension - Comparison with cardiopulmonary exercise testing
S Miyamoto et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
